latest news releases from the newsroom
Nicodrops Featured in Upcoming In-Store Sales Circular From Walgreens
LA MESA, Calif., June 10, 2005 (PRIMEZONE) -- Nicodrops, Inc. (Pink Sheets:NCDP), developer of the drug-free, non-nicotine smoking alternative, herbal dietary supplement, LOZENGE(i), today announced it will be featured in an upcoming in-store sales circular from Walgreens. The in-store sales circular is a weekly promotional piece specifically promoting a number of the better selling products sold at the more than 4,700 Walgreens locations. Nicodrops will be featured in June 12-18 circular at Walgreens. Nicodrops is currently retailing at Walgreens for $9.99. In addition, the Nicodrops ad scheduled to appear in The National Enquirer can be found in the June 20th, 2005 issue on sale NOW and can be seen on page 21.
Wi-Fi TV Inc.
Wi-Fi TV Offers First Internet One-Page, One-Click TV and Phone Calls
NEWPORT BEACH, Calif., June 10, 2005 (PRIMEZONE) -- Starting today, Wi-Fi TV Inc. (Pink Sheets:WFTV) is offering what it believes to be a Internet first: One-Page, One-Click(tm) free and unlimited access to place calls to telephones (local, long distance, and worldwide for calls placed from PCs in the United States and select other territories) and to watch TV (initially 200 stations from around the world and accessible globally). The service requires no registration and no purchase of any additional hardware or software and can be found at www.wi-fitv.com.
SmallCap Sentinel: Potential Impact of Stem Cell Restrictions Questioned
IRVINE, Calif., June 10, 2005 (PRIMEZONE) -- "Limitations on domestic stem cell research may have an impact on major biopharmaceutical companies as well," stated SmallCap Sentinel analyst, D.R. Clark. "It will be interesting to see if the proposed restrictions of stem cell research in the United States eventually impact large pharmaceutical firms, either positively or adversely."
XRG Inc. Completes Reorganization and Secures Additional Financing
PITTSBURGH, June 10, 2005 (PRIMEZONE) -- XRG Inc. (OTCBB:XRGI), a provider of truckload freight and logistics services, today announced the completion of the reorganization initiated in April with the securing of additional funding. Barron Partners LP has agreed to advance XRG up to an additional $1.6 million for working capital and to satisfy outstanding financial obligations. XRG has reached definitive agreements with certain of its operating divisions and details are contained within 8K filings of XRG.
Human Monoclonal Antibody Against West Nile Virus Shows Promise in Animal Studies
LEIDEN, Netherlands, June 10, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announces the discovery of a monoclonal antibody for protection against West Nile virus. Study results have demonstrated that the fully human monoclonal antibody, derived from patients who survived West Nile infection, effectively neutralized the virus in cell culture and fully protected mice from an otherwise lethal infection.
SALE OF MICRO COMPLETED
Bilia's agreement involving the transfer of operations in Micro included terms
relating to the possible transfer of rental agreements to the purchaser. All
the terms of this agreement have now been fulfilled and the deal has been
completed. The day on which possession was taken was 1 June 2005.
Göteborg, 10 June 2005
Bilia AB (publ)
For further information, please do not hesitate to contact Bilia's managing
director and CEO, Jan Pettersson, on +46 31709 55 00.